Paper2178709
Chronic graft-versus-host disease.
Atkinson K. Bone Marrow Transplant, 1990. Cited by 180 papers, by iCite.
Cite this record
ConductScience Library. Chronic graft-versus-host disease. Papers, record 2178709. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2178709
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics3
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Graft vs Host Disease | Major topic |
| Chronic Disease | |
| Humans |
Source PubMed
Cited by36
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 180 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39246931 | Effects and Safety of 5% Lifitegrast Ophthalmic Solution in Patients With Dry Eye Disease Associated With Ocular Graft-Versus-Host Disease. | Cureus | 2024 | https://conductscience.org/library/papers/39246931 | PubMed |
| 38312919 | Cost-Effectiveness of Extracorporeal Photopheresis in Patients With Chronic Graft-vs-Host Disease. | J Health Econ Outcomes Res | 2024 | https://conductscience.org/library/papers/38312919 | PubMed |
| 37842497 | Topical Spironolactone in the Treatment of Ocular Graft-Versus-Host Disease. | Cureus | 2023 | https://conductscience.org/library/papers/37842497 | PubMed |
| 35240319 | Adoptive transfer of ex vivo expanded regulatory T cells improves immune cell engraftment and therapy-refractory chronic GvHD. | Mol Ther | 2022 | https://conductscience.org/library/papers/35240319 | PubMed |
| 30674472 | How I treat refractory chronic graft-versus-host disease. | Blood | 2019 | https://conductscience.org/library/papers/30674472 | PubMed |
| 30546069 | Donor lymphocyte infusions for B-cell malignancies relapse after T-cell replete allogeneic hematopoietic cell transplantation. | Bone Marrow Transplant | 2019 | https://conductscience.org/library/papers/30546069 | PubMed |
| 27374825 | Glycoprotein YKL-40: a novel biomarker of chronic graft-vs-host disease activity and severity? | Croat Med J | 2016 | https://conductscience.org/library/papers/27374825 | PubMed |
| 26538747 | Lichenoid Variant of Chronic Cutaneous Graft Versus Host Reaction Post Blood Transfusion: A Rare Event Post Blood Transfusion. | Indian J Dermatol | 2015 | https://conductscience.org/library/papers/26538747 | PubMed |
| 25355659 | Extracorporeal photopheresis for graft-versus-host disease: the role of patient, transplant, and classification criteria and hematologic values on outcome-results from a large single-center study. | Transfusion | 2015 | https://conductscience.org/library/papers/25355659 | PubMed |
| 25256376 | Effect of exercise therapy on muscle mass and physical functioning in patients undergoing allogeneic hematopoietic stem cell transplantation. | Support Care Cancer | 2015 | https://conductscience.org/library/papers/25256376 | PubMed |
| 25003927 | Histopathologic diagnosis of chronic graft-versus-host disease of the oral mucosa according to the National Institutes of Health Consensus. | Einstein (Sao Paulo) | 2014 | https://conductscience.org/library/papers/25003927 | PubMed |
| 23986066 | Expression and localization of aging markers in lacrimal gland of chronic graft-versus-host disease. | Sci Rep | 2013 | https://conductscience.org/library/papers/23986066 | PubMed |
| 22659679 | Possible involvement of cytokines, chemokines and chemokine receptors in the initiation and progression of chronic GVHD. | Bone Marrow Transplant | 2013 | https://conductscience.org/library/papers/22659679 | PubMed |
| 20307722 | Chronic graft-versus-host disease (GVHD) in children. | Pediatr Clin North Am | 2010 | https://conductscience.org/library/papers/20307722 | PubMed |
| 19770713 | High-frequency topical cyclosporine 0.05% in the treatment of severe dry eye refractory to twice-daily regimen. | Cornea | 2009 | https://conductscience.org/library/papers/19770713 | PubMed |
| 18978736 | Innovative approaches to treat steroid-resistant or steroid refractory GVHD. | Bone Marrow Transplant | 2008 | https://conductscience.org/library/papers/18978736 | PubMed |
| 18850020 | Alefacept treatment for refractory chronic extensive GVHD. | Bone Marrow Transplant | 2009 | https://conductscience.org/library/papers/18850020 | PubMed |
| 17947475 | High levels of B-cell activating factor in patients with active chronic graft-versus-host disease. | Clin Cancer Res | 2007 | https://conductscience.org/library/papers/17947475 | PubMed |
| 17417662 | New clinical grading system for chronic GVHD predicts duration of systemic immunosuppressive treatment and GVHD-specific and overall survival. | Bone Marrow Transplant | 2007 | https://conductscience.org/library/papers/17417662 | PubMed |
| 15701727 | New approaches for preventing and treating chronic graft-versus-host disease. | Blood | 2005 | https://conductscience.org/library/papers/15701727 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2178709
GET https://conductscience.org/api/papers/v1/2178709/cited_by?page=2